Powered by

Regenerative Medicine Leader Michael H. May Joins AgeX Board of Directors

Aug 05, 2019 - Business Wire
Board and Executive Moves

AgeX Therapeutics , Inc. ("AgeX"; NYSE American: AGE), a biotechnology company focused on developing and commercializing innovative therapeutics for human aging, announced today that Michael H. May, Ph.D., has joined its Board of Directors. Dr. May fills a recent vacancy on the Board for an independent member, following the departure of Michael Mulroy, which was not because of a disagreement with AgeX on any matter relating to company operations, policies, or practices.

Dr. May is Presiden...